Reverse genetics through random mutagenesis in Histoplasma capsulatum

Brian H Youseff1, Julie A Dougherty, Chad A Rappleye

  • 1Departments of Microbiology and Internal Medicine, The Center for Microbial Interface Biology, Ohio State University, Columbus, OH 43210, USA. youseff.1@osu.edu

BMC Microbiology
|November 19, 2009
PubMed
Abstract

Insights

Researchers developed a new reverse genetics method to efficiently create gene mutations in Histoplasma capsulatum. This breakthrough aids in understanding fungal pathogens and developing new treatments.

Area of Science:

  • Mycology
  • Pathogen Biology
  • Molecular Genetics

Background:

  • Histoplasma capsulatum is a dimorphic fungus causing disease in mammals.
  • Understanding its biology and pathogenesis is limited by a lack of gene mutation tools.

Purpose of the Study:

  • To develop and validate a novel reverse genetics methodology for Histoplasma capsulatum.
  • To overcome limitations of existing gene knockout techniques in this fungal pathogen.

Main Methods:

  • Agrobacterium-mediated transformation with random mutagenesis.
  • Screening techniques including PCR-addressing for targeted gene disruption.
  • Optimization of cryopreservation for mutant library banking.

Main Results:

  • Successful isolation of a cbp1 mutant in a recalcitrant Histoplasma strain.
  • Demonstration of a functional reverse genetics system for gene targeting.
  • Established cryopreservation protocols for mutant recovery.

Conclusions:

  • The new methodology significantly enhances the ability to isolate targeted gene mutants in Histoplasma.
  • This approach facilitates molecular genetic analysis of fungal biology and pathogenesis.
  • The technique is broadly applicable to other fungi, especially those with inefficient homologous recombination.